 <h1>Nymalize Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>nimodipine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about nimodipine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Nymalize.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> hypotension.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nimodipine: oral capsule liquid filled, oral solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule, Liquid Filled)</p><p>Do not administer nimodipine intravenously or by other parenteral routes. Deaths and serious, life threatening adverse events have occurred when the contents of nimodipine capsules have been injected parenterally.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nimodipine (the active ingredient contained in Nymalize) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking nimodipine:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>chest pain or discomfort</li>
<li>confusion</li>
<li>difficult or labored breathing</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>sweating</li>
<li>swelling</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of nimodipine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach cramps, discomfort, or pain</li>
<li>back pain</li>
<li>blemishes on the skin</li>
<li>constipation</li>
<li>diarrhea</li>
<li>discouragement</li>
<li>feeling sad or empty</li>
<li>headache</li>
<li>indigestion</li>
<li>irritability</li>
<li>lack or loss of appetite</li>
<li>loss of interest or pleasure</li>
<li>muscle pain</li>
<li>nausea or vomiting</li>
<li>pimples</li>
<li>rash</li>
<li>swollen mouth and tongue</li>
<li>tiredness</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>unpleasant taste</li>
<li>urge to have bowel movement</li>
</ul><p>
<!-- end oral capsule liquid filled, oral solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nimodipine: oral capsule, oral liquid</i></p><h3>General</h3><p>The most commonly reported side effects included decreased blood pressure, diarrhea, and rash.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Decreased blood pressure (up to 50%)</p>
<p><b>Common</b> (1% to 10%): Bradycardia, edema, EKG abnormalities, flushing, tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension, vasodilation</p>
<p><b>Frequency not reported</b>: Congestive heart failure, deep vein thrombosis, hematoma, hypertension, palpitations, rebound vasospasm<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastrointestinal symptoms, nausea</p>
<p><b>Rare</b> (0.01% to 0.1%): Ileus</p>
<p><b>Frequency not reported</b>: Gastrointestinal hemorrhage, vomiting<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne, rash</p>
<p><b>Frequency not reported</b>: Diaphoresis, itching<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Cramp, muscle pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Abnormal liver function test</p>
<p><b>Uncommon</b> (0.1% to 1%): Elevated alkaline phosphatase levels, elevated ALT levels</p>
<p><b>Rare</b> (0.01% to 0.1%): Transient increase in liver enzymes</p>
<p><b>Frequency not reported</b>: Hepatitis, jaundice<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Frequency not reported</b>: Alterations in consciousness, dizziness, lightheadedness, neurological deterioration<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p>
<p><b>Frequency not reported</b>: Wheezing<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Decreased platelet counts, thrombocytopenia</p>
<p><b>Frequency not reported</b>: Anemia, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction<sup>[Ref]</sup></p><h3>Local</h3><p><b>Rare</b> (0.01% to 0.1%): Injection site reaction, infusion site phlebitis, infusion site reaction, infusion site thrombophlebitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Phenytoin toxicity<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Elevated lactate dehydrogenase levels, fluid retention, non-fasting elevated serum glucose levels</p>
<p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Nimotop (nimodipine)." Bayer, West Haven, CT. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Nymalize (nimodipine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: calcium channel blocking agents</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nymalize &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nimotop</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Subarachnoid Hemorrhage</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nimodipine: oral capsule, oral liquid</i></p><h3>General</h3><p>The most commonly reported side effects included decreased blood pressure, diarrhea, and rash.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Decreased blood pressure (up to 50%)</p><p><b>Common</b> (1% to 10%): Bradycardia, edema, EKG abnormalities, flushing, tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension, vasodilation</p><p><b>Frequency not reported</b>: Congestive heart failure, deep vein thrombosis, hematoma, hypertension, palpitations, rebound vasospasm<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastrointestinal symptoms, nausea</p><p><b>Rare</b> (0.01% to 0.1%): Ileus</p><p><b>Frequency not reported</b>: Gastrointestinal hemorrhage, vomiting<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne, rash</p><p><b>Frequency not reported</b>: Diaphoresis, itching<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Cramp, muscle pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Abnormal liver function test</p><p><b>Uncommon</b> (0.1% to 1%): Elevated alkaline phosphatase levels, elevated ALT levels</p><p><b>Rare</b> (0.01% to 0.1%): Transient increase in liver enzymes</p><p><b>Frequency not reported</b>: Hepatitis, jaundice<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Frequency not reported</b>: Alterations in consciousness, dizziness, lightheadedness, neurological deterioration<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p><p><b>Frequency not reported</b>: Wheezing<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Decreased platelet counts, thrombocytopenia</p><p><b>Frequency not reported</b>: Anemia, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction<sup>[Ref]</sup></p><h3>Local</h3><p><b>Rare</b> (0.01% to 0.1%): Injection site reaction, infusion site phlebitis, infusion site reaction, infusion site thrombophlebitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Phenytoin toxicity<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Elevated lactate dehydrogenase levels, fluid retention, non-fasting elevated serum glucose levels</p><p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Nimotop (nimodipine)." Bayer, West Haven, CT. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Nymalize (nimodipine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: calcium channel blocking agents</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nymalize &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Subarachnoid Hemorrhage</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>